Why did Ametek (AME) stock move recently?

On 8/4/2026, Ametek moved +4.2% — AMETEK reported record Q2 2026 results with sales up 15% to $2.04B and adjusted EPS up 17% to $2.09, beating expectations, and raised full-year 2026 adjusted EPS guidance to $8.20–$8.30 (from prior $7.94–$8.14). This is MarketChacha's decoded reason from filings and credible news; it is education, not buy/sell advice.

Is Ametek (AME) overvalued or fairly valued?

MarketChacha shows Ametek's valuation in context — a trailing P/E of about 38.0, a forward P/E of about 28.1, a price-to-book of about 5.1 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does Ametek's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (1.29×) from reported figures — education, not a rating.

What is Ametek's revenue?

Ametek reported revenue of $7.4B for FY2025, with net profit of $1.5B, per official filings.

What is the share price of Ametek (AME)?

Ametek last traded at $252.88 (-0.3% on the day), as of 8/10/2026 — a delayed quote shown for education, not investment advice.

Ametek

AME · NYSE · Industrials · United States

Snapshot

TickerAME

ExchangeNYSE

SectorIndustrials

IndustrySpecialty Industrial Machinery

CountryUnited States

Employees22,500

HeadquartersBerwyn, United States

Websitewww.ametek.com

Filings tracked17

About Ametek

AMETEK, Inc. manufactures and sells electronic instruments (EIG) and electromechanical (EMG) devices in the United States and internationally. It operates through EIG and EMG segments. The company offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and metering devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and gas turbines sensors; dashboard instruments for heavy trucks and other vehicles; instrumentation and controls for food and beverage industries; and aircraft and engine sensors, embedded computing, monitoring, power supplies, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry. It also provides engineered medical components and devices, automation solutions, thermal management systems, specialty metals, and electrical interconnects; single-use and consumable surgical instruments, implantable components, and drug delivery systems; engineered electrical connectors and electronics packaging; precision motion control products for data storage, medical devices, business equipment, automation, and other application; high-purity powdered metals, strips and foils, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for thermal management, military and commercial aircraft, and military ground vehicles; and motors used in commercial appliances, food and beverage machines, hydraulic pumps, and industrial blowers, as well as operates a network of aviation maintenance, repair, and overhaul facilities. AMETEK, Inc. was incorporated in 1930 and is headquartered in Berwyn, Pennsylvania.

Who owns it

Insiders0.4%
Institutions92.8%
Public & other6.8%

1,639 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.8.52%
Vanguard Capital Management LLC6.51%
State Street Corporation4.51%
Vanguard Portfolio Management LLC4.30%
Price (T.Rowe) Associates Inc3.02%
Geode Capital Management, LLC2.67%
JPMORGAN CHASE & CO2.03%
FMR, LLC1.90%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Cash conversion1.29×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend19.9% → 20.0%

Margin has held broadly steady over the period — stable profitability.

Growth qualityrev 6% · PAT 6%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $2.2B · EPS 2.17

Est. earnings growth +7.7%

Next fiscal year

Rev $8.7B · EPS 8.98

Est. earnings growth +7.8%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$7.4B

Net margin

20.0%

ROE

13.9%

Revenue CAGR (2y)

+5.9%

Profit CAGR (2y)

+6.2%

EPS (FY2025)

6.40

Net profit (FY2025)

$1.5B

Ask MarketChacha about AME

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

Aug 4, 2026
AMETEK reported record Q2 2026 results with sales up 15% to $2.04B and adjusted EPS up 17% to $2.09, beating expectations, and raised full-year 2026 adjusted EPS guidance to $8.20–$8.30 (from prior $7.94–$8.14).
source 1 ↗source 2 ↗· confidence: high

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$7.4B	$1.5B	6.40	20.0%	13.9%
FY2024	$6.9B	$1.4B	5.93	19.8%	14.3%
FY2023	$6.6B	$1.3B	5.67	19.9%	15.0%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$2.0B	$406.9M	1.77	19.9%
2026Q1	$1.9B	$399.4M	1.74	20.7%
2025Q3	$1.9B	$371.4M	1.60	19.6%
2025Q2	$1.8B	$358.4M	1.55	20.2%
2025Q1	$1.7B	$351.8M	1.52	20.3%
2024Q3	$1.7B	$340.2M	1.47	19.9%
2024Q2	$1.7B	$337.7M	1.45	19.5%
2024Q1	$1.7B	$310.9M	1.34	17.9%
2023Q3	$1.6B	$340.4M	1.47	21.0%
2023Q2	$1.6B	$324.2M	1.40	19.7%
2023Q1	$1.6B	$305.7M	1.32	19.1%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

8-K — Results of operations, Exhibits
SEC8/4/2026material
10-Q filing
SEC8/4/2026
8-K — Material agreement, Material financial obligation, Exhibits
SEC6/12/2026material
8-K — Other events, Exhibits
SEC5/26/2026material
8-K — Shareholder vote results, Exhibits
SEC5/11/2026material
8-K — Executive/director change, Exhibits
SEC5/8/2026material
8-K — Other events, Exhibits
SEC5/6/2026material
8-K — Results of operations, Other events, Exhibits
SEC4/30/2026material
10-Q filing
SEC4/30/2026
10-K filing
SEC2/17/2026
8-K — Other events, Exhibits
SEC2/12/2026material
8-K — Results of operations, Other events, Exhibits
SEC2/3/2026material

2025

8-K — Executive/director change, Exhibits
SEC11/10/2025material
8-K — Results of operations, Exhibits
SEC10/30/2025material
10-Q filing
SEC10/30/2025
8-K — Results of operations, Exhibits
SEC7/31/2025material
10-Q filing
SEC7/31/2025

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.